Tilray Q1: Not Looking Good, Remains A 'Hold'

Impact · against what's priced in

Tilray's fiscal Q1 results indicate a fundamental deterioration in the core business, characterized by declining cannabis sales and escalating cash burn. The significant share dilution further erodes shareholder value, making the stock a hold as the market digests the swing to a loss.

TLRY−0.80

No priced-in read yet

In context

The company reported a 13% decline in core cannabis sales and a surge in cash burn to $23.4 million. Combined with a 31% increase in shares outstanding, the transition to an adjusted loss suggests severe operational headwinds.

Read from the article alone

• TLRYNew
• earnings
• cannabis
• cash burn
• revenue miss
• share dilution

Top 1 mover · tap to explore